Jeffrey A. Meckler, CEO and Director at Indaptus Therapeutics, Inc. (INDP), bought 10,000 shares at $1.76 ($19K) on 2022-11-18, disclosed to the SEC on 2022-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.76 | 400 | $704 | 3.7% |
| 2 | $1.90 | 9,600 | $18K | 96.3% |
| Total | $1.89 avg | 10,000 | $19K | 100% |
| Filing → |
| TVTX | SELL | 2024-09-30 | $562K | — | Filing → |
| INDP | BUY | 2022-09-12 | $29K | — | Filing → |
| INDP | BUY | 2022-09-08 | $25K | — | Filing → |